Vertaling van "trial of antitumor vaccine with dendritic " (Frans → Nederlands) :

Pilot clinical trial of antitumor vaccine with dendritic cells pulsed with multiple HLA-A2 and DP4 peptides and low doses cyclophosphamide to control regulatory T cells, in patients with metastatic lung cancer
Phase I/II study of a re-engineered autologous dendritic cell adjuvant vaccine in resectable non-small cell lung cancer

Feasibility and potency of a IL-12-secreting multi-antigen dendritic cell vaccine in patients with leukemia and myeloma: a two-center trial
Pilot study of neo-adjuvant treatment with galectin-3 inhibitor, GM-CT-01, to stimulate anergized anti-cancer T lymphocytes in ovarian cancer

- Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364:1757- 1765.
- Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus

- Paavonen J, Jenkins D, Bosch FX, Naud P, Salméron J, C. Wheeler et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.
- Paavonen J, Jenkins D, Bosch FX, Naud P, Salméron J, C. Wheeler et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women : an interim analysis of a phase III double-blind, randomised controlled trial.